ArticleCardiovascular diabetology2023

Cardiovascular outcomes with SGLT2 inhibitors versus DPP4 inhibitors and GLP-1 receptor agonists in patients with heart failure with reduced and preserved ejection fraction.

Jimmy Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.